¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Longitudinal reduction defect of fibula"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • longitudinal fissure
    ¼¼·ÎÆ´»õ, Á¾¿­
  • longitudinal fracture
    ¼¼·Î°ñÀý
  • longitudinal layer
    ¼¼·ÎÃþ
  • longitudinal ligament
    ¼¼·ÎÀδë, Á¾Àδë
  • longitudinal magnetization
    ¼¼·ÎÃàÀÚ±âÈ­, Á¾ÃàÀÚ±âÈ­
  • longitudinal plane
    ¼¼·Î¸é, Á¾¸é
  • longitudinal presentation
    ¼¼·ÎÅÂÀ§, Á¾ÅÂÀ§
  • longitudinal scan
    ¼¼·Î½ºÄµ, Á¾Ãེĵ
  • longitudinal section
    1. ¼¼·Î´Ü¸é, Á¾´Ü¸é 2. ¼¼·ÎÀý´Ü, Á¾´Ü
  • longitudinal study
    ÃßÀû¿¬±¸
  • medial longitudinal fasciculus
    ¾ÈÂʼ¼·Î´Ù¹ß, ³»ÃøÁ¾¼Ó
  • superior longitudinal fasciculus
    À§¼¼·Î´Ù¹ß, »óÁ¾¼Ó
  • associated defect
    ¿¬°üÀå¾Ö
  • atrial septal defect
    ½É¹æ»çÀ̸·°á¼Õ, ½É¹æÁ߰ݰá¼Õ
  • atrioventricular canal defect
    ¹æ½Ç°ü°á¼Õ(Áõ)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • longitudinal fracture
    ¼¼·Î°ñÀý
  • longitudinal duodenal fold
    »ùâÀÚ¼¼·ÎÁÖ¸§
  • medial longitudinal fasciculus
    ¾ÈÂʼ¼·Î´Ù¹ß
  • superior longitudinal fasciculus
    À§¼¼·Î´Ù¹ß
  • longitudinal
    ¼¼·Î-
  • longitudinal layer
    ¼¼·ÎÃþ
  • longitudinal ligament
    ¼¼·ÎÀδë
  • longitudinal magnetization
    Á¾ÃàÀÚ±âÈ­, ¼¼·Î¹æÇâÀÚ±âÈ­
  • longitudinal plane
    ¼¼·Î¸é
  • longitudinal presentation
    Á¾ÅÂÀ§, ¼¼·ÎÅÂÀ§
  • longitudinal relaxation
    ¼¼·ÎÃàÇ®¸², ¼¼·ÎÃàÀÌ¿Ï
  • longitudinal scan
    ¼¼·ÎÃེĵ, Á¾Ãེĵ
  • longitudinal section
    ¼¼·Î´Ü¸é
  • longitudinal study
    ÃßÀû¿¬±¸
  • abdominal wall defect
    ¹èº®°á¼Õ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • reduction in area
    ´Ü¸é¼öÃà·ü(Ó¨Øüâ¥õêëÒ).
  • reduction of cardiac work load
    ½ÉÀÛ¾÷·®ÀÇ °æ°¨(ãýíÂåöåÖ¡­ÌîÊõ).
  • reduction of chromosome
    ¿°»öü°¨¼ö(æøßäô÷Êõâ¦).
  • reduction of fraction
    ¾àºÐ(å³ÝÂ).
  • reduction of fracture
    °ñÀý Á¤º¹(Íéï¹ïÚÜÖ).
  • reduction potential
    ȯ¿øÀüÀ§.
  • reduction rhinoplasty
    Ãà¼Òºñ¼ºÇü¼ú
  • reduction semiconductor
    ȯ¿øÇü¹ÝµµÃ¼(ü½êªû¡ÚâÓôô÷).
  • reduction test
    ȯ¿ø½ÃÇè.
  • ECD=£¾endocardial cushion defect
    ½É³»¸·»ó°á¼Õ(Áõ).
  • Interventricular septal defect
    ½É½ÇÁ߰ݰá¼ÕÁõ(ãýãøñḛ́ÌÀáßñø)
  • VSD= ventricular septal defect
    ½É½ÇÁ߰ݰá¼Õ.
  • acquired color vision defect
    ÈÄõ»ö°¢ÀÌ»ó
  • afferent pupillary defect
    ±¸½É¼ºµ¿°ø¿îµ¿Àå¾Ö
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nitrate reduction test
    Áú»ê¿°È¯¿ø½ÃÇè(~ãËúÐ).
  • open reduction
    °³¹æ¼º Á¤º¹(ËÒÛ¯àõïÚÜÖ), °üÇ÷Àû Á¤º¹ °ñÀý(κúìîÜïÚÜÖÍéï¹), ~ÀÇ .
  • oxidation reduction potential
    »êÈ­-ȯ¿øÀüÀ§
  • oxidation reduction potential =redox p.
    »êȭȯ¿øÀüÀ§.
  • oxidation reduction system =redox s.
    »ê ȭȯ¿ø°è.
  • oxidation reduction titration =redox t.
    »ê ȭȯ¿øÀûÁ¤(¡­îÙïÒ).
  • plaque reduction neutralization test
    ÇöóÅ© °¨¼ÒÁßÈ­½ÃÇè
  • plaque reduction test
    ÇöóÅ© °¨¼Ò½ÃÇè
  • pock reduction test
    Æø °¨¼ÒÁßÈ­½ÃÇè
  • proportional reduction
    ºñ·Ê°¨·Â(ÝïçÓÊõæ³).
  • reduction
    Á¤º¹¼ú, °¨¼Ò, Ãà¼Ò
  • reduction
    Á¤º¹, °¨¼Ò
  • reduction
    ȯ¿ø(ü½êª), °¨¼Ò.
  • reduction discharge
    ȯ¿ø¼º¹æ.
  • reduction division
    °¨¼öºÐ¿­
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Medial longitudinal fasciculus
    ¾ÈÂʼ¼·Î´Ù¹ß
    [¿¾ ¿ë¾î] ³»ÃøÁ¾¼Ó
  • Medial longitudinal stria
    ¾ÈÂʼ¼·Î¼¶À¯ÁÙ
    [¿¾ ¿ë¾î] ³»ÃøÁ¾Á¶
  • Anterior longitudinal ligament
    ¾Õ¼¼·ÎÀδë
    [¿¾ ¿ë¾î] ÀüÁ¾Àδë
  • Superior longitudinal fascicle
    À§¼¼·Î´Ù¹ß
    [¿¾ ¿ë¾î] »óÁ¾¼Ó
  • Longitudinal canals of modiolus
    Ã༼·Î°ü
    [¿¾ ¿ë¾î] ¿Í¿ìÃàÁ¾°ü
  • Inferior longitudinal m. of tongue
    Çô¾Æ·¡¼¼·Î±Ù
    [¿¾ ¿ë¾î] ÇÏÁ¾¼³±Ù
  • Superior longitudinal m. of tongue
    ÇôÀ§¼¼·Î±Ù
    [¿¾ ¿ë¾î] »óÁ¾¼³±Ù
  • Defect of thoracic wall
    °¡½¿º®°áÇÔ
    [¿¾ ¿ë¾î] È亮°áÇÔ
  • Defect
    °áÇÔ
    [¿¾ ¿ë¾î] °áÇÔ
  • Canalisation defect
    °üÇü¼º°áÇÔ
    [¿¾ ¿ë¾î] °üÇü¼º°áÇÔ
  • Defect of ear
    ±Í°áÇÔ
    [¿¾ ¿ë¾î] À̰áÇÔ
  • Defect of muscular part
    ±ÙÀ°ºÎºÐ°áÇÔ
    [¿¾ ¿ë¾î] ±ÙºÎ°áÇÔ
  • Functional morphologic defect
    ±â´ÉÇüŰáÇÔ
    [¿¾ ¿ë¾î] ±â´ÉÀûÇüÅÂÇÐÀû°áÇÔ
  • Defect of male urethra
    ³²¼º¿äµµ°áÇÔ
    [¿¾ ¿ë¾î] ³²¼º¿äµµ°áÇÔ
  • Defect of brain
    ³ú°áÇÔ
    [¿¾ ¿ë¾î] ³ú°áÇÔ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • longitudinal relaxation time
    Á¾ÃàÀ̿Ͻð£
  • longitudinal scan
    Á¾´Ü½ºÄµ
  • longitudinal section
    Á¾´Ü¸é
  • OPLL [=ossified posterior longitudinal ligament]
    ÈÄÁ¾Àδ뼮ȸȭ
  • ossified posterior longitudinal ligament [=OPLL]
    ÈÄÁ¾Àδ뼮ȸȭ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
long longitudinal
LPC late positive component; lipocortin; longitudinal primary care [program]; lysophosphatidylcholine
LS lateral suspensor; left sacrum; left septum; left side; legally separated; leiomyosarcoma; length of...
L/S lactase/sucrase [ratio]; lecithin/ sphingomyelin [ratio]; lipid/saccharide [ratio]; longitudinal sec...
LSect longitudinal section
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ONTD open neural tube defect
VFD visual field defect
ARR Absolute risk reduction
ALSPAC Avon Longitudinal Study of Pregnancy and Childhood
BLSA Baltimore Longitudinal Study of Aging
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • auricular defect
    À̰³ °á¼Õ
  • birth defect
    Ãâ»ý °áÇÔ
  • canalisation defect
    °ü Çü¼º °áÇÔ
  • catalase defect
    īŻ¶óÁ¦ °á¼Õ
  • congenital defect
    ¼±Ãµ¼º °á¼Õ, ¼±Ãµ¼º °á¼ÕÁõ, ¼±ÃµÀû °á¼Õ
  • congenital heart defect
    ¼±Ãµ¼º ½É³» °á¼ÕÁõ
  • defect
    °á¼Õ, °á¿©, ±âÇü, °áÇÔ, ºÎÀü, ºÎÀç, ¼Õ»ó
  • ectodermal defect
    ¿Ü¹è¿± °á¼Õ, ¿Ü¹è¿± °á¼ÕÁõ
  • enzymatic defect
    È¿¼Ò °á¼ÕÁõ, È¿¼Ò °á¼Õ
  • filling defect
    Ãæ¸¸ °á¼Õ
  • hearing defect
    û·Â Àå¾Ö
    ºÎºÐÀûÀ¸·Î ȤÀº ¿ÏÀüÈ÷ µé¸®Áö ¾Ê´Â °Í.
  • heart septal defect
    ½É Áß°Ý °á¼Õ, ½É Áß°Ý °á¼ÕÁõ
  • interventricular septal defect
    ½É½Ç Áß°Ý °á¼ÕÁõ
  • metabolic defect of amino acid
    ¾Æ¹Ì³ë»ê ´ë»ç °áÇÔ
    ¾Ëİſ ´¢Áõ.
  • metabolic defect of pigment
    »ö¼Ò ´ë»ç °áÇÔ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
closed reduction The physical manipulation of a joint or bone externally (without making a surgical incision) to affect a joint relocation or more proper anatomic alignment of broken bone fragments. Closed reductions are often performed using intravenous analgesics, local anaesthetic nerve blocks or regional anaesthesia.
(27 Sep 1997)
closed reduction of fractures Reduction by manipulation of bone, without incision in the skin.
(05 Mar 2000)
Motulsky dye reduction test A test for glucose-6-phosphate dehydrogenase deficiency in the blood, using a mixture of brilliant cresyl blue, glucose-6-phosphate, and NADP.
(05 Mar 2000)
pregnancy reduction, multifetal Selective abortion of one or more embryos or foetuses in a multiple gestation pregnancy. The usual goal is to improve the outcome for the remaining embryos or foetuses.
(12 Dec 1998)
Schmorl's ferric-ferricyanide reduction stain <technique> A stain to test for reducing substances in tissues, including melanin, argentaffin granules, thyroid colloid, keratin, keratohyalin, and lipofuscin pigments; ferricyanide is converted into ferrocyanide which is converted to insoluble Prussian blue in the presence of ferric ions.
(05 Mar 2000)
selective reduction <obstetrics> A technique for intrauterine termination of one or more foetuses while leaving one or more foetuses undisturbed, usually in pregnancies with foetal anomalies or with multiple gestations.
(05 Mar 2000)
source emission reduction plan (SERP) A contingency plan developed to reduce emissions during an air quality emergency.
(05 Dec 1998)
nitroblue tetrazolium reduction <chemical> Nitroblue tetrazolium, a yellow dye, is taken up by phagocytosing neutrophils and reduced to insoluble formazan, which is deep blue, if the metabolic burst is normal. Reduction does not take place in chronic granulomatous disease.
(18 Nov 1997)
internal reduction The relocation of a joint or realignment of a fracture through a surgical incision. most internal reductions utilise general anaesthesia.
(27 Sep 1997)
open reduction of fractures Reduction by manipulation of bone, after incision in skin and muscle over the site of the fracture.
(05 Mar 2000)
oxidation-reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs.
(12 Dec 1998)
oxidation-reduction electrode An electrode capable of measuring oxidation-reduction potential.
See: quinhydrone electrode.
Synonym: redox electrode.
(05 Mar 2000)
oxidation-reduction indicator A substance that undergoes a definite colour change at a specific oxidation potential.
Synonym: redox indicator.
(05 Mar 2000)
oxidation-reduction potential <chemistry, physics> The potential in volts of an inert metallic electrode measured in a system of an arbitrarily chosen ratio of [oxidant] to [reductant] and referred to the normal hydrogen electrode at absolute temperature.
It is calculated from the following equation: where R is the gas constant expressed in electrical units, T the absolute temperature (Kelvin), n the number of electrons transferred, F the faraday and E0 the normal symbol for the potential of the system at pH 0; for biological systems E0' is often used (in which pH = 7).
Compare: Nernst's equation.
Synonym: redox potential.
(05 Mar 2000)
oxidation-reduction reaction <chemistry> Any reaction in which electrons are removed from one molecule or atom and given to another molecule or atom.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á